Dr. Oettgen received his medical degree from the University of Connecticut in 1987. After completing his internship and residency in Internal Medicine at the New England Medical Center in Boston, MA, he went on to train in Cardiology at Beth Israel Hospital in Boston, MA. He is currently an Associate Professor of Medicine at Harvard Medical School, the Director of Preventive Cardiology, and the Associate Chief of the Division of Molecular and Vascular Medicine at Beth Israel Deaconess Medical Center. He joined the Cardiology faculty at Beth Israel Deaconess Medical Center in 1993, and established an independent laboratory and research program at the Harvard Institutes of Medicine in 1997.
As the Director of Preventive Cardiology, he directs an outpatient prevention program called the Cardiovascular Health and Lipid Center where patients with hypertension and a variety of lipid disorders treated. His major research interests and contributions include determining the molecular mechanisms of vascular inflammation, angiogenesis, and vascular development with a particular focus on the role of ETS transcription factors in these processes. The ultimate goal of these studies is to identify novel therapeutic approaches to cardiovascular disease.
Dr. Oettgen is an Established Investigator of the American Heart Association. He has served as a reviewer on several NIH and AHA study sections and is currently serving as an extramural special advisor for the Vascular Biology and Hypertension Branch of the NHLBI. He is a reviewer for several journals including Journal of Clinical Investigation, Circulation, Circulation Research, ATVB, and the Journal of Biological Chemistry.